In this context, Smc5/6 is crucial to compensate for deficiencies in the RecQ helicase Sgs1/BLM, mutated in cancer-prone Bloom syndrome patients, likely by its role in modulating resolution or remodeling of the emerging recombination intermediates (Figure 4G). This evidence concerns the gene SMC5 and cancer.